Extended Research Article
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
Steven J Edwards
,
Charlotta Karner
,
Tracey Jhita
,
Samantha Barton
,
Gemma Marceniuk
,
Zenas Z N Yiu
et al.
-
Journal:
Health Technology Assessment Volume: 28, Issue: 4
-
Published:
30 January 2024